跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TELFAST ORAL LIQUID fexofenadine hydrochloride 6mg/mL oral suspension bottle (reformulation) - TGA Drug Approval Details
Approvals
/
TGA
/
TELFAST ORAL LIQUID fexofenadine hydrochloride 6mg/mL oral suspension bottle (reformulation)
Approved
STANDARD
TELFAST ORAL LIQUID fexofenadine hydrochloride 6mg/mL oral suspension bottle (reformulation)
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
b4b3728df4d3e80c
Company
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Type
Standard
Approval Details
Approval Id
b4b3728df4d3e80c
Product Name
TELFAST ORAL LIQUID fexofenadine hydrochloride 6mg/mL oral suspension bottle (reformulation)
Artg Id
418214
Artg Name
TELFAST ORAL LIQUID fexofenadine hydrochloride 6mg/mL oral suspension bottle (reformulation)
Sponsor
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Company Detail Path
/organization/sanofi-aventis-healthcare-pty-ltd
Artg Date
2023-08-15
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-02244-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-PI-01894-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
b4b3728df4d3e80c
Type
Standard
Back to TGA Approvals